graduation at Farmácia from Universidade de Uberaba (2010), master's at Química from Universidade Estadual Paulista Júlio de Mesquita Filho (2012) and doctorate at Pharmacy from Universidade Estadual Paulista Júlio de Mesquita Filho (2016). Has experience in Chemistry, acting on the following subjects: nanomedicina, quitosana, quality by design, análise térmica and química ambiental. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The market for innovative cosmetic and pharmaceutical products is growing and fundamentally dependent on the use of excipients with properties capable of conferring physical-chemical stability to the active ingredient and the finished product while also bringing benefits for cosmeceutical and/or therapeutic actions. In this aspect, materials such as poloxamers and amphiphilic meglumine sa…
Currently, one of the main causes of fungal infections has been associated with Candida albicans, a microorganism present in normal microbiota. However, due to its opportunistic nature, these microorganisms can trigger infections, especially due to their ability to form biofilms on the skin and mucous membranes, as is the case with candidiasis. It is known that pomegranate fruit peels (Pu…
Carotenoids are organic compounds that have been widely studied for their potential health benefits due to their antioxidant properties, contributing to the prevention of various diseases, such as chronic non-communicable diseases, cataracts, diabetic retinopathy, age-related macular degeneration, obesity, hypertension arterial and age-related muscular disorders. However, its instability …
The most serious cases of COVID-19 are manifested by a state of pulmonary hyperinflammation caused by a cytokine storm, which occurs due to the infection of the lower airways by the SARS-CoV-2 virus. Under these conditions, diffuse alveolar damage leads to severe acute respiratory disease (SARS), with a high mortality rate. Mucus-modulating nanoparticles are potentially useful in the pulm…
Monoclonal antibodies represent an important class of biopharmaceuticals with a wide therapeutic application, especially against cancer. Bevacizumab, a monoclonal antibody to be used in this study, was recently approved for the treatment of glioblastomas. It acts by preventing the process of angiogenesis which accompanies tumor tissue and in combination with cytotoxic drugs can reduce the…
Glioblastoma (GBM), the most malignant primary brain tumors, are characterized by highly aggressive and invasive growth throughout the brain that can be contributed to activating multiple oncogenic pathways including vascular endothelial growth factor (VEGF) signaling. The VEGF is the main factor involved in the pathological angiogenesis of GBM. The targeted therapy with the monoclonal an…
| 1 / 1 | Ongoing grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 6 / 6 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID